Growth Metrics

Neuroone Medical Technologies (NMTC) Gross Profit (2020 - 2026)

Neuroone Medical Technologies filings provide 11 years of Gross Profit readings, the most recent being $1.3 million for Q1 2026.

  • On a quarterly basis, Gross Profit rose 66.86% to $1.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.3 million, a 69.76% increase, with the full-year FY2025 number at $5.1 million, up 376.2% from a year prior.
  • Gross Profit hit $1.3 million in Q1 2026 for Neuroone Medical Technologies, down from $1.6 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.9 million in Q4 2024 to a low of -$36223.0 in Q1 2022.
  • Median Gross Profit over the past 5 years was $266314.0 (2023), compared with a mean of $557313.9.
  • Biggest five-year swings in Gross Profit: crashed 71.49% in 2022 and later skyrocketed 3899.56% in 2023.
  • Neuroone Medical Technologies' Gross Profit stood at -$12307.0 in 2022, then skyrocketed by 2263.92% to $266314.0 in 2023, then soared by 623.54% to $1.9 million in 2024, then decreased by 18.63% to $1.6 million in 2025, then fell by 17.94% to $1.3 million in 2026.
  • The last three reported values for Gross Profit were $1.3 million (Q1 2026), $1.6 million (Q4 2025), and $1.5 million (Q3 2025) per Business Quant data.